DIVA Laboratories, Ltd. (TPEX:4153)
Taiwan · Delayed Price · Currency is TWD 30.25
-0.70 (-2.26%)
Nov 6, 2026, 1:30 PM CST
DIVA Laboratories Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,775 | 2,048 | 2,244 | 2,159 | 2,379 | 1,572 | |
Market Cap Growth | -15.97% | -8.76% | 3.94% | -9.25% | 51.31% | 8.06% |
Enterprise Value | 1,338 | 1,564 | 1,703 | 1,700 | 2,146 | 1,265 |
Last Close Price | 30.25 | 32.74 | 34.24 | 31.98 | 34.40 | 22.41 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.50 | 22.62 | 23.96 | 29.33 | 47.91 | 71.94 |
Forward PE | - | 14.20 | 14.20 | 14.20 | 14.20 | 14.20 |
PS Ratio | 1.88 | 2.36 | 2.60 | 2.42 | 2.51 | 2.21 |
PB Ratio | 1.78 | 1.99 | 2.13 | 2.09 | 2.34 | 1.59 |
P/TBV Ratio | 1.78 | 1.99 | 2.13 | 2.09 | 2.34 | 1.61 |
P/FCF Ratio | 27.38 | 102.94 | 18.45 | 8.80 | 37.86 | - |
P/OCF Ratio | 25.18 | 98.59 | 18.22 | 8.54 | 32.51 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.41 | 1.80 | 1.98 | 1.90 | 2.26 | 1.78 |
EV/EBITDA Ratio | 9.60 | 14.35 | 14.36 | 16.94 | 23.06 | 37.16 |
EV/EBIT Ratio | 10.26 | 15.30 | 15.32 | 18.44 | 25.30 | 55.97 |
EV/FCF Ratio | 20.63 | 78.65 | 14.01 | 6.93 | 34.15 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0 | 0 |
Debt / EBITDA Ratio | 0.01 | 0.03 | 0.04 | 0.07 | 0.00 | 0.01 |
Debt / FCF Ratio | 0.02 | 0.15 | 0.04 | 0.03 | 0.01 | - |
Net Debt / Equity Ratio | -0.44 | -0.48 | -0.55 | -0.51 | -0.34 | -0.30 |
Net Debt / EBITDA Ratio | -3.24 | -4.50 | -4.92 | -5.28 | -3.72 | -8.78 |
Net Debt / FCF Ratio | -6.74 | -24.69 | -4.80 | -2.16 | -5.51 | 12.70 |
Asset Turnover | 0.71 | 0.65 | 0.68 | 0.72 | 0.78 | 0.62 |
Inventory Turnover | 2.50 | 3.01 | 3.46 | 2.50 | 2.03 | 1.76 |
Quick Ratio | 2.18 | 2.48 | 3.54 | 3.69 | 2.76 | 2.62 |
Current Ratio | 3.03 | 3.35 | 4.18 | 4.70 | 4.16 | 4.55 |
Return on Equity (ROE) | 11.53% | 8.69% | 8.97% | 7.19% | 4.96% | 2.21% |
Return on Assets (ROA) | 6.01% | 4.81% | 5.45% | 4.62% | 4.36% | 1.23% |
Return on Invested Capital (ROIC) | 22.53% | 16.87% | 18.43% | 13.17% | 9.17% | 2.57% |
Return on Capital Employed (ROCE) | 12.90% | 9.90% | 10.50% | 8.90% | 8.30% | 2.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.45% | 4.42% | 4.17% | 3.41% | 2.09% | 1.39% |
FCF Yield | 3.65% | 0.97% | 5.42% | 11.37% | 2.64% | -1.50% |
Dividend Yield | 6.61% | 5.73% | 5.23% | 3.40% | 2.47% | 1.38% |
Payout Ratio | 101.99% | 129.60% | 78.30% | 79.69% | 43.71% | 69.80% |
Buyback Yield / Dilution | -0.04% | -0.02% | -0.03% | -0.13% | -0.07% | 11.69% |
Total Shareholder Return | 6.58% | 5.71% | 5.20% | 3.27% | 2.40% | 13.07% |